Discovering

A disciplined, highly targeted approach to discovering new cancer medicines

Go

Developing

Rigorous, definitive clinical trials based on deep oncology expertise

Go

Delivering

Committed to bringing differentiated new cancer medicines to patients

Go

Iclusig®(ponatinib)

ARIAD's first internally discovered and developed medicine

Go
       

Approved in the U.S., EU & Australia: Iclusig® (ponatinib)

An ARIAD-developed medicine

Learn more See full prescribing information, including BOXED WARNING.

A remarkable place doing remarkable work

We’re looking for people who want to make a difference for cancer patients

Open Positions

A unique, highly targeted approach to cancer

Our research & development program

Learn more

News & Features

Latest News

7/22/15

ARIAD to Webcast Conference Call on Second Quarter 2015 Financial Results

Read More

6/12/15

ARIAD Announces Long-Term Safety and Efficacy Data of Ponatinib from Phase 2 Pace Clinical Trial

Read More

Our Company Video

A shared commitment to patients and each other. This is ARIAD.

Our Company Video
 
Click here to watch
Print page Share page
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue